ArticleEndocrinology2025
Suppression of Luteinizing Hormone Secretion in Female Mice by a Urocortin 2-CRHR2 Signaling Pathway.
Article in Endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Physiologic stress elicits impairment of reproductive function, in part, by the suppression of luteinizing hormone (LH) secretion. Two populations of kisspeptin-synthesizing neurons in the hypothalamus play essential roles in controlling the pulsatile and surge modes of LH secretion and are potential direct targets of stress-activated neural circuits; however, the mechanism(s) for impairment of kisspeptin cells during stress remain unclear. Here, we conducted 4 experiments to test the hypothesis that corticotropin-releasing hormone receptor 2 (CRHR2) signaling contributes to impaired pulsatile and surge LH secretion via direct actions on kisspeptin cells. First, we observed that cells expressing a specific ligand of CRHR2, urocortin 2 (UCN2), show enhanced c-Fos in the paraventricular nucleus (PVN) following acute hypoglycemia, a metabolic stressor that rapidly suppresses LH pulses by impairing arcuate kisspeptin neuron activation. Second, we determined that central injection of UCN2 rapidly inhibits LH pulses. Furthermore, UCN2 disrupts evening expression of the estradiol-induced LH surge and reduces kisspeptin cell activation in the rostral periventricular hypothalamic region (RP3V). Next, we identified CRHR2 in a majority of both arcuate and RP3V kisspeptin cells. Finally, we observed that UCN2 cells in the PVN are activated following chemogenetic stimulation of catecholamine neurons in the nucleus of the solitary tract. Together these data demonstrate that UCN2-CRHR2 signaling disrupts the pulsatile and surge modes of LH secretion via direct suppression of kisspeptin cells. Furthermore, these findings suggest UCN2 cells in the PVN are regulated by metabolic stress and brainstem norepinephrine signaling pathways that convey stress cues to the hypothalamus.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.